WHO announces start of Ebola vaccine clinical trial in DR Congo
The World Health Organization has announced that a clinical trial testing several vaccines has begun in the Democratic Republic of the Congo. It will assess their safety, efficacy and immunogenicity.
The World Health Organization (WHO), the United Nations' specialised health agency, has announced the start of a clinical trial in the Democratic Republic of the Congo. The study is testing vaccines against Ebola, a severe viral infection.
According to the WHO announcement, the trial will examine several vaccines. They will be assessed on three measures: safety, efficacy and immunogenicity. Immunogenicity refers to a vaccine's ability to provoke an immune response in the body.
The source text gives no further details, such as which vaccines are being tested, how many participants are involved, where the trial is taking place or what the timeline is. Those details are not yet known, and the report will be updated if they become available.
